Sort
40,608 grants matching “prostate cancer”
Project 1: Combined Suppression of MYC as therapy for CRPC: the COSMYC trial
$377,111Samuel R Denmeade · Johns Hopkins University · P50 · FY2025 · CA
Time-resolved FRET-based allostery sensors for any protein kinase drug target
$377,096Nicholas Mark Levinson · University Of Minnesota · R33 · FY2021 · CA
MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis
$377,072Larisa Nonn · University Of Illinois At Chicago · R01 · FY2016 · CA
Hsp60 Regulation of Prostate Cancer Progression
$377,062Dhyan Chandra · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Hsp60 Regulation of Prostate Cancer Progression
$377,062Dhyan Chandra · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
TP53 Germline Mutations: Beyond LFS
$377,037Yong Li · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Deciphering Mechanisms of Tumor-Stromal Interactions in Prostate Cancer
$377,020Boyang Wu · Washington State University · R01 · FY2023 · CA
Elucidating the Role of UCHL1 in Aggressive Prostate Cancer
$376,947Tanya I Stoyanova · Stanford University · R01 · FY2020 · CA
Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition
$376,931Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Hybrid Intelligence for Trustable Diagnosis And Patient Management of Prostate Cancer (HIT-PIRADS)
$376,880Ulas Bagci · Northwestern University At Chicago · U01 · FY2023 · CA
The Aged Microenvironment as a Contributor to Carcinogenesis
$376,880Judith Campisi · University Of Washington · U54 · FY2009 · CA
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$376,866Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · GM
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$376,866Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · GM
Substrate Specificity Determinants in Nutrient Solute Carrier Transporters
$376,866Avner Schlessinger · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · GM
Harms of Hepatocellular Carcinoma Screening in Patients with Cirrhosis
$376,765Amit Singal · Ut Southwestern Medical Center · R01 · FY2022 · CA
Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention
$376,753Baowei Fei · Emory University · R01 · FY2017 · CA
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$376,735Katherine Nelson Weilbaecher · Ohio State University · P01 · FY2020 · CA
Development of Castration Resistance by Alternative AR Splicing
$376,724Stephen R Plymate · Beth Israel Deaconess Medical Center · P01 · FY2014 · CA
DNA damage signaling to immune checkpoints
$376,715Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · CA
Sequence-specific Hybridization Capture for Discovery of ProteoformâlncRNA Interactions in Prostate Cancer
$376,661Lloyd M Smith · University Of Wisconsin-Madison · R01 · FY2024 · CA
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers
$376,647James A Eastham · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer
$376,588Koon Y Pak · Molecular Targeting Technologies, Inc. · R44 · FY2010 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$376,543Selina M Luger · University Of Pennsylvania · U10 · FY2011 · CA
Progenitor cell states contributing to aging and lung cancer
$376,504Marcia Haigis · Harvard Medical School · U01 · FY2024 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$376,493Selina M Luger · University Of Pennsylvania · U10 · FY2012 · CA